Pasithea Therapeutics Corp. (KTTAW) Restructuring Costs (2022 - 2025)

Pasithea Therapeutics has disclosed Restructuring Costs across 2 years of filings, most recently posting $45.0 for Q2 2025.

• In Q2 2025, Restructuring Costs changed N/A year-over-year to $45.0; the TTM figure through Dec 2025 stood at $700.0 (changed N/A YoY), while the FY2025 annual figure was $700.0, changed N/A from the prior year.
• Restructuring Costs came in at $45.0 for Q2 2025 at Pasithea Therapeutics, down from $655.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $326380.0 in Q1 2022 to a low of $45.0 in Q2 2025.